On Jan 11, 2022 Zhenge Biotech closed a Series C round and raised $100,000,000 from Cowin Capital, Goldman Sachs Asset Management, IDG Capital, Junxin Yingtai Investment, LYFE Capital, Novo Holdings, Qiming Venture Partners, Sofina, featuring lead investors Goldman Sachs Asset Management, Sofina.

About the company: Zhenge Biotech is located at China, Asia.

Company website: http://www.zgbiotech.com

Leave a Reply

Your email address will not be published. Required fields are marked *